OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies
Alejandro Olivares-Hernández, Luis Figuero-Pérez, Eduardo Terán-Brage, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1919-1919
Open Access | Times Cited: 5
Alejandro Olivares-Hernández, Luis Figuero-Pérez, Eduardo Terán-Brage, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1919-1919
Open Access | Times Cited: 5
Showing 5 citing articles:
Exploring the Emerging Association Between Immune Checkpoint Inhibitors and Thrombosis
Hassan Fawaz, Hasan Numan, Mohamad Hadi El Charif, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 10, pp. 3451-3451
Open Access
Hassan Fawaz, Hasan Numan, Mohamad Hadi El Charif, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 10, pp. 3451-3451
Open Access
TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy
Hui Qiu, Zhiying Shao, Xin Wen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 19
Hui Qiu, Zhiying Shao, Xin Wen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 19
New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology
Nikoleta Bizymi, Andreas Μ. Matthaiou, Angelos Matheakakis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5326-5326
Open Access | Times Cited: 11
Nikoleta Bizymi, Andreas Μ. Matthaiou, Angelos Matheakakis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5326-5326
Open Access | Times Cited: 11
Targeting myeloid-derived suppressor cells to attenuate vasculogenic mimicry and synergistically enhance the anti-tumor effect of PD-1 inhibitor
Yinan Li, Kailiang Qiao, Xiaoyun Zhang, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103392-103392
Open Access | Times Cited: 10
Yinan Li, Kailiang Qiao, Xiaoyun Zhang, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103392-103392
Open Access | Times Cited: 10
Reactivation of Anticancer Immunity by Resetting Interorgan Crosstalk in Immune‐Suppressive Cells with a Nanoparticulated Anti‐Inflammatory Drug
Mizuki Doi, Hiroki Tanaka, Takara Ohoto, et al.
Small (2023) Vol. 19, Iss. 16
Open Access | Times Cited: 2
Mizuki Doi, Hiroki Tanaka, Takara Ohoto, et al.
Small (2023) Vol. 19, Iss. 16
Open Access | Times Cited: 2
Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
Nikoleta Bizymi, Helen Α. Papadaki
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 187-187
Open Access | Times Cited: 3
Nikoleta Bizymi, Helen Α. Papadaki
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 187-187
Open Access | Times Cited: 3
